| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |